Drug Profile
Research programme: influenza virus immunotherapeutics - GlobeImmune
Alternative Names: GI-8000Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator GlobeImmune
- Class
- Mechanism of Action Immunomodulators; T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Influenza-virus-infections in USA (SC)
- 16 Mar 2016 Influenza virus immunotherapeutics - GlobeImmune is available for licensing as of 16 Mar 2016. https://www.globeimmune.com/
- 07 Oct 2007 Preclinical trials in Influenza virus infections in USA (SC)